PHIO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Phio Pharmaceuticals Corp (PHIO) is not a strong buy at this moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock lacks significant positive catalysts, has weak financial performance, and no clear technical or proprietary trading signals supporting an immediate buy decision.
The technical indicators show a neutral trend. The MACD is below zero and negatively expanding, indicating bearish momentum. The RSI is neutral at 51.177, and moving averages are converging, suggesting no clear direction. The stock is trading near its pivot level of 1.269, with resistance at 1.322 and support at 1.215.
NULL identified. No recent news, hedge fund activity, insider trading, or congress trading data to suggest a positive catalyst.
The stock also has a 40% chance of declining in the next day and week based on candlestick pattern analysis.
In Q4 2025, the company reported no revenue growth (0% YoY), a net income loss of -$2.37M (improved by 45.82% YoY), and a significant EPS drop of -82.52% YoY. Gross margin remains at 0%.
No analyst rating or price target changes available.
